The erythroid/myeloid lineage fate paradigm takes a new player

Jian Xu; Stuart H. Orkin

doi:10.1038/emboj.2011.45

The erythroid/myeloid lineage fate paradigm takes a new player

Jian Xu, Stuart H. Orkin

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The erythroid versus myeloid lineage fate decision controlled by cross-antagonism between GATA1 and PU.1 serves as a mechanistic paradigm for transcription factor interplay during lineage specification. In this issue of The EMBO Journal, Monteiro et al (2011) examined this paradigm in blood populations in zebrafish embryos, and demonstrated that, unexpectedly, the regulatory interactions between GATA1 and PU.1 lead to different outcomes depending on the cellular contexts and the development stages. GATA1/PU.1 cross-antagonism is also modulated by a third factor transcriptional intermediate factor 1γ (TIF1γ), a chromatin-associated haematopoietic regulator.

Original language	English (US)
Pages (from-to)	983-985
Number of pages	3
Journal	EMBO Journal
Volume	30
Issue number	6
DOIs	https://doi.org/10.1038/emboj.2011.45
State	Published - Mar 16 2011

ASJC Scopus subject areas

General Neuroscience
Molecular Biology
General Biochemistry, Genetics and Molecular Biology
General Immunology and Microbiology

Access to Document

10.1038/emboj.2011.45

Cite this

@article{73a169086112416b99a98eaf095ec9f9,

title = "The erythroid/myeloid lineage fate paradigm takes a new player",

abstract = "The erythroid versus myeloid lineage fate decision controlled by cross-antagonism between GATA1 and PU.1 serves as a mechanistic paradigm for transcription factor interplay during lineage specification. In this issue of The EMBO Journal, Monteiro et al (2011) examined this paradigm in blood populations in zebrafish embryos, and demonstrated that, unexpectedly, the regulatory interactions between GATA1 and PU.1 lead to different outcomes depending on the cellular contexts and the development stages. GATA1/PU.1 cross-antagonism is also modulated by a third factor transcriptional intermediate factor 1γ (TIF1γ), a chromatin-associated haematopoietic regulator.",

author = "Jian Xu and Orkin, {Stuart H.}",

year = "2011",

month = mar,

day = "16",

doi = "10.1038/emboj.2011.45",

language = "English (US)",

volume = "30",

pages = "983--985",

journal = "EMBO Journal",

issn = "0261-4189",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - The erythroid/myeloid lineage fate paradigm takes a new player

AU - Xu, Jian

AU - Orkin, Stuart H.

PY - 2011/3/16

Y1 - 2011/3/16

N2 - The erythroid versus myeloid lineage fate decision controlled by cross-antagonism between GATA1 and PU.1 serves as a mechanistic paradigm for transcription factor interplay during lineage specification. In this issue of The EMBO Journal, Monteiro et al (2011) examined this paradigm in blood populations in zebrafish embryos, and demonstrated that, unexpectedly, the regulatory interactions between GATA1 and PU.1 lead to different outcomes depending on the cellular contexts and the development stages. GATA1/PU.1 cross-antagonism is also modulated by a third factor transcriptional intermediate factor 1γ (TIF1γ), a chromatin-associated haematopoietic regulator.

AB - The erythroid versus myeloid lineage fate decision controlled by cross-antagonism between GATA1 and PU.1 serves as a mechanistic paradigm for transcription factor interplay during lineage specification. In this issue of The EMBO Journal, Monteiro et al (2011) examined this paradigm in blood populations in zebrafish embryos, and demonstrated that, unexpectedly, the regulatory interactions between GATA1 and PU.1 lead to different outcomes depending on the cellular contexts and the development stages. GATA1/PU.1 cross-antagonism is also modulated by a third factor transcriptional intermediate factor 1γ (TIF1γ), a chromatin-associated haematopoietic regulator.

UR - http://www.scopus.com/inward/record.url?scp=79952767340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952767340&partnerID=8YFLogxK

U2 - 10.1038/emboj.2011.45

DO - 10.1038/emboj.2011.45

M3 - Article

C2 - 21407249

AN - SCOPUS:79952767340

SN - 0261-4189

VL - 30

SP - 983

EP - 985

JO - EMBO Journal

JF - EMBO Journal

IS - 6

ER -

The erythroid/myeloid lineage fate paradigm takes a new player

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this